Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling
{{output}}
Background: Cardiorenal syndrome type 4 (CRS4) arises from the chronic kidney disease, and currently, there is a lack of therapies specifically target the dual pathological mechanisms of CRS4, namely mitochondrial dysfunction and... ...
